CHINESE BIOLOGICAL INVESTIGATORS S… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1997

Legal Domicile

Principal Officer

DR YIBIN KANG

Phone

8585396266

Tax Period

2020-01-01 to 2020-12-31

CHINESE BIOLOGICAL INVESTIGATORS SOCIETY INC, founded in 1997, is a micro nonprofit in the Diseases & Disorders sector that reported $67K in total revenue in fiscal year 2020. Revenue surged 58% from the prior year, signaling strong growth momentum. The organization ran a surplus of $63K, a strong 94% operating margin.

Mission

PART I, LINE 1 FOR MISSION STATEMENT.

Program Service Accomplishments

Program 1

Expenses: $932

TO ORGANIZE INTERNATIONAL SCIENTIFIC MEETINGS TO PROVIDE OPPORTUNITIES FOR EXCHANGE OF INFORMATION AMONG SCIENTISTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2020)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $66,658

Other Revenue $0

TOTAL REVENUE $66,658

Expense Breakdown

Grants Paid $0

Salaries & Benefits $420

Fundraising Expenses $0

Program Expenses $932

Other Expenses $3,341

TOTAL EXPENSES $3,761

Year-over-Year Comparison

	2020	2019	Change
Revenue	$66,658	$42,303	+0.6%
Expenses	$3,761	$30,999	-0.9%
Net Income	$62,897	$11,304	+4.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$420

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
YIBIN KANG PHD	PRESIDENT	6.00	Officer Director	$0	$0	$0
YINGZI YANG PHD	VICE PRESIDENT	2.00	Officer Director	$0	$0	$0
JING YANG PHD	TREASURER	4.00	Officer Director	$0	$0	$0
LEE ZOU PHD	SECRETARY	2.00	Officer Director	$0	$0	$0
LINGLING CHEN PHD	DIRECTOR	1.00	Director	$0	$0	$0
CHARLENE LIAO PHD	DIRECTOR	1.00	Director	$0	$0	$0
XIN SUN PHD	DIRECTOR	1.00	Director	$0	$0	$0
ZHENYU YUE PHD	DIRECTOR	1.00	Director	$0	$0	$0
LIN HE PHD	DIRECTOR	1.00	Director	$0	$0	$0
FENG SHAO PHD	DIRECTOR	1.00	Director	$0	$0	$0
HONGTAO YU PHD	DIRECTOR	1.00	Director	$0	$0	$0
MING XIOMING ZHANG PHD	EXECUTIVE SECRETARY	2.00	Director	$420	$0	$420

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2020	$66,658	$3,761	$1,105,354	$62,897
2019	$42,303	$30,999	$1,021,736	$11,304
2018	$117,630	$9,707	$897,257	$107,923

CHINESE BIOLOGICAL INVESTIGATORS SOCIETY INC